February 10, 2023 February 10, 2023Categories Announcements News StoriesThe January/February 2023 News from ECOG-ACRIN blog is now available
December 20, 2022 December 20, 2022Categories Announcements News StoriesThe November/December 2022 News from ECOG-ACRIN blog is now available
October 26, 2022 October 26, 2022Categories Press ReleasesPress Release: NCI-MATCH cancer trial finds a promising signal for the AKT inhibitor ipatasertib
October 20, 2022 October 20, 2022Categories Announcements Press ReleasesPress Release: ECOG-ACRIN taps the University of Pennsylvania’s Selina Luger to lead its Leukemia Committee
October 13, 2022 October 13, 2022Categories Announcements News StoriesThe September/October 2022 News from ECOG-ACRIN blog is now available
August 16, 2022 August 16, 2022Categories Announcements News StoriesThe August 2022 News from ECOG-ACRIN blog is now available
June 22, 2022 June 22, 2022Categories News StoriesFDA approves dabrafenib plus trametinib for BRAF V600E-mutated tumors based on data from NCI-MATCH
June 1, 2022 June 1, 2022Categories News StoriesPrecision medicine clinical trials: A conversation between Peter O’Dwyer and Lale Kostakoglu
May 27, 2022 May 27, 2022Categories Press ReleasesPress Release: ECOG-ACRIN research highlights at ASCO 2022
